Cell-free DNA promoter hypermethylation in plasma as a predictive marker for survival of patients with pancreatic adenocarcinoma-Reference-Cited by-同舟云学术

Cell-free DNA promoter hypermethylation in plasma as a predictive marker for survival of patients with pancreatic adenocarcinoma

Published:2017-09-30 Issue:55 Volume:8 Page:93942-93956
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Henriksen Stine Dam¹²³⁴,Madsen Poul Henning⁵,Larsen Anders Christian¹,Johansen Martin Berg⁶,Pedersen Inge Søkilde⁵,Krarup Henrik⁴⁵,Thorlacius-Ussing Ole¹³⁴

Affiliation:

1. Department of Gastrointestinal Surgery, Aalborg University Hospital, Aalborg, Denmark

2. Department of General Surgery, Hospital of Vendsyssel, Hjørring, Denmark

3. Department of Clinical Medicine, Aalborg University, Aalborg, Denmark

4. Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark

5. Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark

6. Unit of Clinical Biostatistics and Bioinformatics, Aalborg University Hospital, Aalborg, Denmark

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical significance of tumor suppressor genes methylation in circulating tumor DNA of patients with pancreatic cancer;Gene;2024-03

2. Jingfang Granules May Improve Early Pancreatic Cancer by Modulating Immune Response Through RUNX3;Natural Product Communications;2024-03

3. Epigenetic therapeutic strategies in pancreatic cancer;International Review of Cell and Molecular Biology;2024

4. Molecular biomarkers in pancreatic ductal adenocarcinoma;Biomarkers in Cancer Detection and Monitoring of Therapeutics;2024

5. Diagnosing and monitoring pancreatic cancer through cell-free DNA methylation: progress and prospects;Biomarker Research;2023-10-05